Generics BulletinDr Reddy’s and Alvotech have struck a further biosimilars alliance, announcing today a co-development partnership for a rival to Merck & Co/Merck Sharp & Dohme’s top-selling Keytruda (pembroli
ScripA high-profile expert panel that included renowned clinician-scientist and director of the Cancer Science Institute of Singapore, Prof Ashok Venkitaraman, discussed some of the pressing global public
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On
ScripNobody knows, at least for now, how the “end game” for potential tariffs by the US will play out and companies like Dr Reddy’s Laboratories (DRL) are preparing for “all options” and to primarily secur